Biocatalysis 2014; 1: [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] chemical unconventional computing approaches. Indeed, the modern Si-chip analog/digital computer technology has been one of the most successful and influential transformative developments in recent history. We are now in the decade when for the first time the Moore's law of exponential performance speed-up and componentsize scaling-down of modern computers is coming to a halt at the "physics" level. Computers and other devices are now made faster primarily at the "architecture" level (e.g., multi-cores, different chip designs, parallelization approaches). Therefore, interest in various alternative, "unconventional" information processing ideas and technologies has transcended basic-science research value, acquiring a certain degree of practical urgency for several reasons.
examples mostly related to enzyme biocatalytic reactions performing computational operations. However, it should be understood that the real application of biomolecular computing is more related to the low-scale information processing similar to the operation of biosensors rather than real computers.
Enzyme-biocatalyzed reactions recently found unusual applications outside the scope of traditional biochemical research. They were applied for biomolecular information processing ("biocomputing") and for triggering changes in switchable signalresponsive materials, electrodes and nano-structured multi-component systems. Recent advances in signal responsive electrodes using smart materials triggered by various inputs, being biochemical/chemical, magnetic, or light signals, etc., along with progress in biochemical logic operations, signal amplification, and filters for noise reduction or concentration dependent triggering, have made new opportunities possible in 'Sense-and-Treat' systems and personalized medicine. The development of novel electrochemically coupled 'Sense-and-Treat' systems for future biomedical and ease-of-care opportunities in disease management is of great interest in the scientific community. Boolean logic operations can be used in combination with mechanical and electrochemical components to perform logic operations such as AND, OR, NOR, etc., as well as giving YES/NO responses, ultimately resulting in the activation of a release process. These systems can also be combined with biochemical signal amplification, allowing for increased sensitivity; this will be specifically useful in cases where a biomarker is present at very low concentrations and will allow for the biosensing tool to operate at normal, amplified levels. The electronically coupled electrode systems can be tuned to operate in response to specific diseases with threshold biomarker concentrations being established using biomolecular and chemical filters. Biosensing systems integrated with smart signal responsive materials offer great potential in personalized medicine and have the ability to benefit a wide range of scientific fields, from biomedical research to environmental health assessments and food quality control. Combining the sensing system with the actuating element of these systems allows for easier, direct administration or detection in response to a specific biomarker or biomarker concentration. The development of smart 'Sense-and-Treat' combinations and ease-of-care procedures for chronic and long lasting illnesses, such as diabetes, are essential to the future of medicine.
Unconventional computing
Recently, a novel direction of unconventional computing has emerged involving chemical and biochemical systems where the variation of the concentrations of reactive species allows some control over the processes [1] . Signal processing using a Boolean logic system can be achieved using unconventional computing through the collective formation of logic systems [2] [3] [4] [5] [6] [7] . Chemical and biochemical systems can mimic different traditional computing operations and electronic elements, such as memory units [8, 9] , switches [10] , and complex logic gates [11] . It is important to note that this form of unconventional computing is not trying to compete with traditional silicon based computers, but rather provide an interface between electronic and biological systems.
Boolean Logic
Logic gates involve a device operating a Boolean function; a Boolean function performs a logical operation involving one or a combination of logical inputs resulting in a binary output of 1/0 or YES/NO, respectively. Boolean logic operations are specific in their function. An AND gate, for example, returns logic-1 only when both inputs are provided and logic-0 when either one or both is missing. Intuitively, an OR gate operates where in the presence of either input the output value is 1. These electronic functions can be applied to biomolecular systems, using specific reactions as the gate pathways and the presence or absence of a chemical or biochemical as the 1/0 input values. Using these biochemical logic gates, a variety of Boolean functions can be performed, including AND, OR, XOR, NAND, and NOR (Scheme 1) [12, 13] . 
Biomolecular Machinery
Logic operations can be performed using various biomolecular machinery, such as proteins [14] [15] [16] [17] [18] [19] or DNA [20] [21] [22] [23] . Use of these biomolecules as logic components allows for computing in a biosensing system based on biochemical or chemical inputs, which can be biomarkers and, consequently, be used for injury diagnoses or biosensing [24] [25] [26] [27] and the triggering of a relevant release system [28] .
Enzymes
Enzymes can act as both inputs [12] and fixed machinery [25] in biochemical logic. Immobilization of enzymes on a solid support, allowing them to act as the logic machinery, is preferable for future applications in biosensors and bioelectronics [29] . Enzymes as inputs also offer advantages. Elevated concentrations of some enzymes are common in diseases and injuries, allowing the enzymes to act as biomarkers for diagnosis [30] . Injury logic gates can be constructed to accurately identify injuries or diseases based on the elevated concentrations of enzymes in the body. These systems can be difficult to construct due to the non-zero levels of the biomarkers at normal physiological conditions, but can be mitigated with further use of biochemical logic and filtering operations [31, 32] .
Small molecules
Small molecules, such as substrates and cofactors, are routinely used as inputs in biomolecular logic. Manipulation of physiological inputs allows the transformation of one input into an output that can perform a function or trigger a release process. This is important given that actuation must usually be triggered by a specific signal. The inputs or biomarkers typically do not include the necessary trigger needed to initiate the release process. Using enzymes, small molecules can be manipulated into the correct trigger for the release process to occur [30] .
Antibodies
Immune-recognition is an appealing tool in biocomputing given its inherent specificity and selectivity, advancing biocomputing systems by allowing increased complexity with less cross-reactivity. Systems have been designed using immune-species with the demonstrated ability to logically process immune-specific interactions in combination with enzyme-based logic networks and their biochemical signals (Scheme 2) [33] . In order to produce a readable signal from immune complex formation the immune species (antibodies) were labeled with biocatalytic enzymes. The enzyme biocatalyzed reaction proceeded only upon completing the recognition process, thus converting the immune interactions to biocatalytic processes. This approach is appealing for biomedical applications [34] , expanding decision making in biomolecular arrangements concatenated with actuating systems to include immune signals and responses, resulting in novel monitoring and autonomous treatment of patients. 
Application of Biomolecular Logic
Systems: The Biocomputing Toolbox
Sensing
Since their first prototype in 1962 [35] biosensors have been designed around the same general concept: an analyte species is processed through a biomolecular reaction generating a chemical signal which is then transduced to an electronic one. The advantage offered by biomolecular sensing is the high specificity for the biorecognition of the analyte. The chemical outputs transduction to an electronic signal is usually achieved by electrochemical [36] , optical [37] , or other [38] physical methods. In order to do this, the biosensor array includes a biosensing interface integrated with the transduction module, power supply, and an electronic unit such as a computer for finally processing and reading the results (Scheme 3). Typically, the concentration of the biomarker is proportional to the output signal, giving a linear curve. Usually, a biosensor senses a single particular analyte, glucose [39] , for example. It is possible to sense multiple analytes at once using biosensor arrays [40] . These arrays are usually processed by a computer for a reliable and readable output. Challenges in biosensing include the spanning of multiple inputs over wide concentration ranges as well as a lack of YES/NO answers for when fast qualitative analysis is desired.
Biocomputing allows a new approach to multiinput biosensors using Boolean logic operations such as AND, OR, XOR, NOR, NAND, INHIB, XNOR, etc. These operations were realized in biomolecular systems [41] . Networks composed of biomolecular logic gates in series or in parallel, using both Boolean and non-Boolean elements (enzyme based multiplexers and filters) can mimic their electronic equivalents [42] . This approach becomes especially useful in biosensing for biomedical analysis where a pathophysiological condition is detected. Diagnostic conclusions become complex and difficult when the analyte is present at small concentrations in a complex matrix, resulting in interferences with the biosensor from compounds of similar nature in much higher concentrations. Ultimately, the species that is considered a biomarker may not be specific or significant enough to result in a definitive answer. Using a cascade of biomolecular reactions with limited selectivity can solve issues in biosensing, analyzing biomarkers at higher concentrations that may only be definitive of a condition where two biomarkers are present or elevated. Analysis of this nature requires design of a logic network processing each input analyte at physiological and pathophysiological concentrations for biomedical relevance.
Actuating
Signal-responsive "smart" materials can be designed to respond to different physical and chemical signals [43] . Integration of these materials with modified electrodes that can switch between ON and OFF states by various methods [44] allows actuation based on information processing biocomputing systems, resulting in the ability to perform actuation resulting from biochemical signals logically processed according to Boolean logic [45, 46] . These systems have been used in biofuel cells [47] , mechanical actuators [48] , substance-releasing systems [49] , and in biosensing [45, 50] . Of particular interest are biochemical systems responding to specific biochemical signals to release a bioactive species. Biocomputing logic systems integrated with actuating systems are promising for use in theranostics, especially for closedloop biomedical systems [51] , and for the advancement of technology towards personalized medicine [52] .
Filtering
A major challenge in biomolecular computing and, in particular, its use as a diagnostic tool, involves accumulation of noise [53] . Physiological levels of inputs in biomolecular sensing are rarely zero as is common in an idealized laboratory experiment where logic-0 corresponds to concentration zero. Inputs must be distinguishable between their physiological levels and pathophysiological levels, affording a significant difference in the resulting output of a biocomputing system acting as a diagnostic tool triggering actuation. Poor separation between logic-0 and logic-1 outputs can lead to problems that cannot be adjusted electronically in the case where the output is directly coupled with a release system. In this case, prolonged accumulation of the logic-0 output can lead to a false logic-1 readout of the system, triggering a drug release process even in the case that the individual is healthy [54, 55] . In order to solve this problem of noise build up, other biochemical [31] or chemical [32] components can be integrated to reduce the noise levels, usually transforming a convex response from an enzymatic cascade into a sigmoidal response [31, 32, [56] [57] [58] , significantly improving the signal-to-noise ratio.
Filtering of a biochemical response is something in contrast to optimization of biochemical reactions. Optimization can be achieved by varying the readout time or changing chemical concentrations. This method does not solve the problem presented in physiological systems, however, where accumulation of the logic-0 output occurs. Output discrimination is better tuned using chemical or biochemical filters. These filters usually change the kinetics of the response, moving away from a convex curve produced by most systems to a sigmoidal response [59] . Development of these filters is essential for biochemical logic networks, solving differentiation issues between logic-0 and logic-1 outputs in biomedical scenarios. Many of these chemical or biochemical filters have been designed [31, 32, 56, 58] becoming a valuable tool to the 'toolbox' of biosensing and actuating.
A multi-input sensing system using a biochemical filter
Biocomputing using biochemical logic gates allows the processing of multiple inputs using machinery such as proteins or enzymes [18, 42] , DNA [60] , and even whole cells [61] . They can perform complex logic operations by using combinations of many concatenated logic gates with both Boolean and non-Boolean elements. When applying these systems to solve biomedical problems or to use as diagnostic tools, it rarely occurs where one very specific biomarker can be used, for reasons such as low concentrations or elevated levels that are not specific to the injury. To solve this issue, multiple less specific markers can be combined to form a conclusive result. Multi-enzyme and multi-input biochemical logic networks can be constructed with multiple pathways, processing the inputs in a logical manner to generate a YES/NO output as an optical, chemical, or electrochemical signal. This multi-input approach can increase the specificity and the robustness of the biocomputing system [56] , which lead to better outcomes when the sensor's output signal is used to activate a release process.
One such multi-input system [56] is activated by two biomarkers for liver injury (LI) [62] , alanine transaminase (ALT) and lactate dehydrogenase (LDH) (Fig. 1) . Each of these biomarkers by themselves are not indicative of LI, however, together, they serve as a good indicator [63] . The two biomarkers, ALT and LDH, serve as two inputs in a biocatalytic cascade acting as an AND gate. The final result in the case of logic-1 is a decrease in the optical signal of reduced nicotinamide adenine dinucleotide (NADH). Physiologically at logic-0 the concentrations of the biomarkers are not concentration 0. As a results, there is a signal for the logic-0 output that is comparable with logic-1. In order to solve this problem a filter process was added using glucose-6-phosphate-dehydrogenase (G6PDH), converting some of the reduced NAD + back to NADH. The system succeeds in two ways: (1) use of two biomarkers presents a much more definitive and selective response for LI than a single marker at a lower concentration and (2) addition of the filter makes the cascade robust and decisive, displaying this quality by being performed in human serum solutions [55] . The flexibility of expanding an enzyme logic network allows the system, in subsequent experiments, to be tuned from an optical output to an output that could include a release process or activate a signal-responsive electrode.
Signal responsive electrodes: switchable electrochemical interfaces
A switchable electrochemical interface refers to an electrode where the surface responds to a signal rapidly because of a transition between two states. Functionalized switchable electrode interfaces, responsive to external or applied signals, properties not indicative of their bare conducting counterparts, have become of great use in electroanalytical systems [64] and fuel cells [65] . Particularly, bioelectrochemical systems [66, 67] , for use in biosensors [28, 68] and biofuel cells [69, 70] , possess novel bioelectrocatalytic properties. Functionalization with signal responsive materials allows switchable, tunable surfaces controlled by external signals, such as pH changes [71] , light [72] , magnetic field [73] , potential [74] , or chemical or biochemical signals [75] . Switchable electrode interfaces are of interest for future biomedical applications where they are controlled by specific biomarker concentrations.
Electrodes

Light-switchable electrodes
Light switchable modified electrodes allow switchable nature upon irradiation with different light signals via interfaces functionalized with photoisomerable species (Fig. 2) [72] . The immobilized species only facilitate electron transfer based on changing the conformation or charge of the molecule. The mechanism of these reactions is dependent on the specific immobilized organic species. Light switchable electrode surfaces with photoisomerable species were used for information processing in optoelectronic devices, such as flip-flop memory units [8] .
Magneto-switchable electrodes
Magneto-switchable electrodes are controlled by the application or removal of an external magnetic field and the consequent rearrangement of the magnetic species, such as magnetic beads [76] [77] [78] [79] [80] or nanorods [81] [82] [83] [84] . In the absence of a magnetic field, the magnetic species are suspended in the solution and are not interacting directly with the electrode surface, resulting in little or no electrochemical response of the redox species. Upon application of a magnetic field, the magnetic particles assemble and are integrated with the conducting support, increasing the size of the electrode and facilitating electron transfer and subsequent redox activity (Fig. 3) [73] .
Electrodes switchable by applied potential
Applied potential can also be used to induce changes at an electrode surface, and so, substantially change the electrochemical properties at the surface of that electrode [85] . These changes can occur using a bare conducting surface or through functionalization of a surface with a redox polymer, opening and closing, due to specific signals resulting from an applied electrochemical potential (Fig. 4) [74].
Chemically/biochemically switchable electrodes
Finally, of special interest are systems where chemical or biochemical signals can act as molecular ON/ OFF switches when integrated with signal responsive materials [86] [87] [88] . The mechanism is specific to the receptor unit which will bind specific chemicals or biochemicals, changing the interfacial properties of the receptor, and so, the redox properties or the ability of a redox species to access the electrode (Fig. 5) [75] . These responsive systems are promising for the integration of release systems with results from a physiological process, eventually leading to personalized medicine and reducing the problems associated with patient compliance, drug concentrations, and physiological similarities to how the body would naturally respond in cases such as diabetes. 
Coupling of Signal Responsive Electrodes with Biomolecular Computing Systems
As signal responsive electrodes are developed, their complexity must be able to be scaled up in order to work with different signals and in specific situations.
Physical signals, such as light or a magnetic field, are difficult to be concatenated in networks allowing for multi-input versatile responsive systems. Biomolecular computing allows the formulation of complex systems that can process information, resulting in logic networks responding to multiple chemical or biochemical inputs. Connection of these logic systems with signal responsive electrodes allows for electrode responses to chemicals or biochemicals in a predictable and structured way [89, 90] . These sensing and actuating chemical devices have been developed using physiologically relevant biomarker concentrations for diseases. A system was developed [45] where biomarkers for liver injury, alanine transaminase, ALT, and lactate dehydrogenase, LDH, were logically processed by a biocatalytic system acting as an AND gate (Fig. 6A) . The output signal, in this case NAD + , was produced by the system only in the presence of both biomarkers, which was then converted biocatalytically to a pH signal. The pH signal, ultimately a response produced in the presence of the biomarkers (Fig. 6B) , triggered a response in the signal responsive electrode and switched the electrochemical process ON (Fig. 6C) . In this configuration, small concentration changes of the input signal (NADH/ NAD + ) amplified the output signal significantly. 
Alginate
Recently, functional materials based on polymer thin films have been developed, such as membranes [91] , capsules [92] [93] [94] , and liposomes [95, 96] , and are able to entrap species and release them upon a physical or chemical signal. Alginate, a naturally available polymer, offers advantages such as compatibility with hydrophobic as well as hydrophilic molecules and mechanical and adhesive properties [97] . Of particular importance is alginate's biodegradability in physiological conditions [97] making it an ideal material for biomedical applications, and maintaining full biological activity of various species, including proteins/enzymes [98] [99] [100] , DNA [101, 102] , and cells [103, 104] . It can even help stabilize proteins or enzymes, increasing the lifetime of a system [97] . Signal triggered drug release has been achieved using a novel, biocompatible, electrochemically responsive material able to incorporate biomolecules into its matrix [105] . Alginate is a linear copolymer made up of 1,4-linked β-D-mannuronic acid (M) and epimeric α-L-guluronic acid residues (G) [106] . The sodium or potassium salts of the alginic acid allow for a viscous aqueous solution. This solution can become a hydrogel through the crosslinking of the polymer. This is achieved using metal cations [107, 108] , the most commonly of which is Ca
2+
. The mechanism of this chelation has been determined; the arrangement of the G and M residues with the Ca 2+ form an "egg-box" where four G subunits interact with one Ca 2+ [109] . (Fig. 7) . Fe 3+ however interacts strongly with the polymer and results in crosslinking of the alginate chains, similar to Ca 2+ [108] . Iron-ion-cross-linked alginate, therefore, has the ability to be electrochemically controlled.
Iron-alginate
Gelation
Iron-alginate gelation can be accomplished multiple ways, two of which are controlled immersion of viscous alginate droplets into an Fe 3+ crosslinking solution and electrochemical oxidation of Fe 2+ ions already present in the viscous alginate. The former produces iron-alginate beads (Fig. 8A) while the latter produces an iron-alginate favourable due to the high degree of control of irradiation precision using photolithography.
Structure
Alginate can be manipulated in three distinctive forms: beads, thin films, and bulk gels. Beads and thin films are of most relevance to drug release and biomedical applications. Beads can be tailored in size for injection, acting as controlled release capsules, and thin films are useful in electrochemically controlled situations. thin film on a solid conducting support (Fig. 8B) . Both methods can be tuned to vary the properties of the resulting gel. The size of the beads, macro-micro-nanoetc, is controlled using airflow to push the droplets out of a holding chamber. Thin film formation and thickness can be precisely controlled by the duration of the application of the positive potential (Fig. 9). 
Dissolution
Dissolution of iron-alginate can be accomplished chemically, using citric acid, for example, or electrochemically, by reducing the Fe 3+ to Fe 2+ . Electrochemical dissolution is favorable; it allows precise control over the dissolution process by manipulation of the electrochemical potential applied [105] . Chemical dissolution can also be useful, however. This would apply to situations where the output of an injury logic gate could directly interact with the alginate and cause dissolution and consequent release of the entrapped drug [30] . A third method of dissolution using UV-irradiation has also been investigated. Melman et al demonstrate the photo induced dissolution of a bulk alginate gel by irradiation with UV or visible light [110] . Photochemical reduction of Fe 3+ to Fe 2+ and subsequent gel dissolution was achieved in the presence of carboxylic acids, in this case small concentrations of sodium lactate. This method is 
Beads
Beads are of particular interest for in vivo applications of iron-alginate. In order to be successful, the alginate should be scalable in size. Beads offer this versatility. They also allow for augmentation with other chemicals or polymers to increase or tune their mechanical stability. The beads can be coated for structural support [111] making them tuneable not only in size but also in their release kinetics.
Recently, the application of alginate nanocapsules for diagnosis and treatment of liver injury was reported. Drug-releasing alginate microspheres were triggered using a signal-processing biocomputing system for the diagnosis of liver injury based on the enzymes alanine transaminase (ALT) and aspartate transaminase (AST) (Fig. 10) [30] . These biomarkers for liver injury were applied at their physiological and elevated pathophysiological levels. At the elevated levels, the inputs were converted in significant concentrations to citrate, resulting in dissolution of the alginate spheres and release of the model drug, in this case rhodamine 6G dye. The spheres mechanical stability was improved using a poly-L-lysine (PLL) coating, followed by another alginate coating for maintaining biocompatibility.
Thin films
Polymer thin films have moved from acting as a means to biocompatibility through coating of structural matrices to acting as the bioactive material themselves. Thin films allow the entrapment of cells [112] , nanoparticles [113] , or proteins [105] , to name a few. These entrapped specials are entrapped on a solid support, like an electrode [105] , which offers structural stability. The film can later be controllably chemically degraded or manipulated by current [105] , pH [114] , or temperature [115, 116] , for example.
Oxidation of Fe 2+ ions in the presence of soluble alginate and a desired protein or drug-mimicking molecule results in the formation of an alginate thin film at the electrode surface through Fe 3+ cations having a strong one vehicle or system, identifying a problem and selecting a treatment, solving multiple problems presented by current modes of action in medicine.
Integration of Concepts: Biosensing to Actuating
Functional materials allow for stimuli-triggered controlled release of a desired substance and find application in fragrance release [120] , self-healing materials [121, 122] , or particularly for biomedical applications pertaining interaction with alginate (Fig. 11) . The thin-film can be disrupted by application of a negative potential, and resulting reduction of iron back to Fe
2+
, weakly interacting with alginate, and so, reverting back to its viscous state. Bovine serum albumin (BSA) was used as a model protein drug [105] , demonstrating future applications in the case of an electrochemical signal. The thickness of the desired layer was controlled electrochemically, allowing precise thicknesses to be developed on the electrode (Fig. 9) . The nature of the deposition and the resulting electrode were characterized electrochemically (Fig. 12) . The system demonstrates a controlled, tunable drug-releasing process with a model protein (BSA).
'Sense & treat' systems
Integration of biochemical logic systems (biocomputing) in combination with signal responsive electrodes built with stimuli responsive materials allows the assembly of autonomous sensing and releasing platforms. Electrode properties can be switched based on a Boolean logic program using biochemical signals. This enables chemical systems to respond to a stimulus and release a loaded bioactive substance (a drug, for example) [117, 118] . These systems are of particular interest for interfacing between chemical and biological platforms, particularly for the development of closed-loop medicine [51] . This concatenated process has recently been referred to as theranostics [119] , therapy and diagnostics combined in to the delivery of a bioactive substance [123] [124] [125] [126] [127] . When combined with biocomputing 'programs' able to serve as an interface to a biological component and translate biochemical inputs into conclusive YES/NO outputs, 'Sense-and-Treat' systems for biomedical applications are realized. The advantages of closed-loop sensing and drug releasing platforms are abundant and will be outlined shortly. Integration of sensing with releasing platforms processing physiological signals will result in the development of "smart" constructs operating autonomously and revolutionizing the field of medicine, ultimately resulting in the development of personalized medicine [52] , a long awaited concept in the research and medical community.
Integration of the sensing and actuating can be done in two general ways: (1) the sensing component can be directly integrated with the releasing component, acting on the same solid support, or electrode, with direct communication between them based on a change in interfacial properties, or (2) the two system components, the sensing and releasing platforms, can be developed on different materials, two different electrodes, and communicate electrically. The former presents challenges in versatility and the design of the system must be very complex. The latter offers advantages in flexibility, easy development, and broader ranges of use. An iron-crosslinked alginate electrode loaded with a bioactive species, electrically connected with a second bioelectrocatalytic electrode processing biochemical signals and producing a negative potential, acts as a versatile 'Sense-and-Treat' system that can be modified and tuned to numerous biomedical scenarios.
Theranostics
Theranostics is a relatively new term and refers to the combined technology of imaging or diagnosis with therapeutic effects (Fig. 13) [117, 128, 129] . The approach focuses on improved patient outcomes, solving problems of bioavailability and toxicity, as well as solving any problems in differences in selectivity or specificity between imaging and treatment technologies [129] .
The theranostic approach offers the opportunity to monitor the biodistribution and efficacy of the treatment closely while the therapy is being administered. The approach also addresses several clinical needs in medicine, including a therapy that responds to changing dynamics within the body, which is of particular importance in the case of diabetes management. Natural physiological fluctuations can lead to decreased therapeutic effects of drugs and even to serious complications due to an unresponsive system in a dynamic environment.
There are several things to keep in mind when designing theranostic systems. Perhaps most obviously, the platform of the material must be biocompatible. Long-term studies must be performed to ensure no accumulation and adverse effects. In regards to implantable systems, the tissue/material interface must allow for seamless integration of the technology into the body. Also, the bioavailability and control of the therapy through transport mechanisms must be understood and optimized, allowing for the best possible therapeutic scenario. Finally, the optimal theranostic system would have the capability to adjust its therapeutic effect based on diagnostic feedback from the body, and, after processing this information itself, controlling and tuning its actions without any external input.
Closed-loop versus open-loop
Controlled drug release is achievable on different levels, varying the complexity of the setup and what it must do to function properly. Two classifications of these 'smart' systems are closed-loop and open-loop. Openloop systems require some mediator between analysis of the input and function of the system, requiring some sort of external regulation that then applies the trigger to perform the drug delivery. Stimulations used in these systems include ultrasonic irradiation [130] [131] , application of a magnetic field [132] , electrical stimulation [133] , photo-stimulation [134] , and chemical or biochemical stimulation [135, 136] . Conversely, closed-loop systems are self-modulating, inducing a change when an input is detected without any need for external input. These systems utilize many technologies, including system response to temperature variations [137] , pH changes [138] , and systems responding to some chemical or biochemical input [139] .
Advantages
Closed-loop 'Sense-and-Treat' systems offer numerous advantages to the biomedical sector. They can respond much like your body would respond to an injury or medical problem, eliminating high and then low concentrations of a drug in the bloodstream from a one-time dose, and maintaining a long-term therapeutic concentration [51] . They also eliminate the need for frequent invasive procedures, finger sticks required by diabetics to check blood glucose levels, for example. Importantly, for rapidly developing situations where it is important to be treated quickly, epilepsy, for example, the medicine would be available as soon as the episode took place, activated by your body's signal that it has begun. Most importantly, however, closed-loop systems eliminate the possibility of a lack of patient compliance or patient error when dosing themselves with prescribed medication. A recent World Health Organization study showed that one ½ of patients who suffer from chronic diseases take their medications wrong either from lack of compliance or by accident [140] . These problems can easily be solved by advancing medical technology to where injury detection and drug administration is a seamless interaction between two integrated components, working together to provide fast, accurate, and safe medical care.
Outlook
Biochemical computing based on concepts from unconventional computing and logic-gate systems find application in the field of biosensors, specifically for the interfacing of biocomputing and biosensing with signalresponsive materials for theranostics or closed-loop medicine. Multi-analyte analysis resulting in a digital YES/NO output generated from biochemicals, processing data, and working in cooperation with signal-responsive materials have the chance to revolutionize medicine, leading to closed-loop sense and treat technologies. Overall, this research is imperative to the development of smart 'Sense-and-Treat' medicine and ease-of-care procedures for chronic and long lasting illnesses, such as diabetes. Figure 13 : A theranostic structure with key components: a targeting moiety, therapeutic agents, detection components for non-invasive imaging, and, in this case, a polymer matrix or coating for drug loading, stability, or to provide functional groups for bioconjugation [117] (Reproduced with permission from ref. 117 . Copyright (2011) American Chemical Society).
